Liver regeneration: molecular mechanisms of growth control - PubMed
- ️Mon Jan 01 1990
Review
. 1990 Feb 1;4(2):176-87.
Affiliations
- PMID: 2404819
Review
Liver regeneration: molecular mechanisms of growth control
G K Michalopoulos. FASEB J. 1990.
Abstract
The molecular signals controlling liver regeneration are becoming rapidly defined. Control of growth in regenerating liver has advanced from elusive serum factors and nutrient effects to identification of entirely new growth factors with apparent liver specificity as well as establishment of meaningful gene expression patterns for growth factors already known. Based on studies with hepatocyte cultures and gene expression in regenerating liver, the substances EGF, TGF alpha, HBGF-1 (aFGF), and two new substances (HPTA/HGF and Hepatopoietin B) have been defined as complete mitogens for hepatocytes and implicated in control of liver growth. The amino acid sequence of HPTA/HGF recently became clear and revealed interesting structural homologies in a molecule that might become the largest known growth factor. The plasticity of growth responses seen in liver may be controlled by these factors as well as by comitogenic substances such as norepinephrine which, although nonmitogenic per se, can initiate growth in hepatocytes exposed to the above mitogenic growth factors or mitogenic inhibitors such as TGF beta. The role of the latter in cessation of DNA synthesis in liver regeneration will be discussed, presenting the positive and negative evidence that constitutes the TGF beta paradox of liver regeneration.
Similar articles
-
Zarnegar R, Michalopoulos G. Zarnegar R, et al. Cancer Res. 1989 Jun 15;49(12):3314-20. Cancer Res. 1989. PMID: 2524251
-
Fausto N, Webber EM. Fausto N, et al. Crit Rev Eukaryot Gene Expr. 1993;3(2):117-35. Crit Rev Eukaryot Gene Expr. 1993. PMID: 8324292 Review.
-
Characterization of the effects of human placental HGF on rat hepatocytes.
Hernandez J, Zarnegar R, Michalopoulos GK. Hernandez J, et al. J Cell Physiol. 1992 Jan;150(1):116-21. doi: 10.1002/jcp.1041500116. J Cell Physiol. 1992. PMID: 1370501
-
Synergistic enhancement of EGF, but not HGF, stimulated hepatocyte motility by TGF-beta 1 in vitro.
Stolz DB, Michalopoulos GK. Stolz DB, et al. J Cell Physiol. 1997 Jan;170(1):57-68. doi: 10.1002/(SICI)1097-4652(199701)170:1<57::AID-JCP7>3.0.CO;2-K. J Cell Physiol. 1997. PMID: 9012785
-
Matsumoto K, Nakamura T. Matsumoto K, et al. Crit Rev Oncog. 1992;3(1-2):27-54. Crit Rev Oncog. 1992. PMID: 1312869 Review.
Cited by
-
Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors.
Francavilla A, Azzarone A, Carrieri G, Scotti-Foglieni C, Zeng QH, Cillo U, Porter K, Starzl TE. Francavilla A, et al. Hepatology. 1992 Nov;16(5):1267-70. Hepatology. 1992. PMID: 1427665 Free PMC article.
-
Gene therapy for liver regeneration: experimental studies and prospects for clinical trials.
Atta HM. Atta HM. World J Gastroenterol. 2010 Aug 28;16(32):4019-30. doi: 10.3748/wjg.v16.i32.4019. World J Gastroenterol. 2010. PMID: 20731015 Free PMC article. Review.
-
Meredith K, Haemmerich D, Qi C, Mahvi D. Meredith K, et al. Ann Surg. 2007 May;245(5):771-6. doi: 10.1097/01.sla.0000261319.51744.59. Ann Surg. 2007. PMID: 17457170 Free PMC article.
-
PI3K/Akt activation is critical for early hepatic regeneration after partial hepatectomy.
Jackson LN, Larson SD, Silva SR, Rychahou PG, Chen LA, Qiu S, Rajaraman S, Evers BM. Jackson LN, et al. Am J Physiol Gastrointest Liver Physiol. 2008 Jun;294(6):G1401-10. doi: 10.1152/ajpgi.00062.2008. Epub 2008 Apr 3. Am J Physiol Gastrointest Liver Physiol. 2008. PMID: 18388186 Free PMC article.
-
Condreay JP, Condreay LD, Huber BE. Condreay JP, et al. In Vitro Cell Dev Biol Anim. 1997 Apr;33(4):228-31. doi: 10.1007/s11626-997-0037-y. In Vitro Cell Dev Biol Anim. 1997. PMID: 9156333 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources